Establishing new assays typically requires a major investment of effort and capital. Are your manpower levels stretched thin? Would you like to save both time and money? Let CTL’s team of experts handle the details for you.
CTL has been providing contract research services to government laboratories, major pharmaceutical companies, biotechnology companies, and academic institutions for nearly a decade. Our company has been recognized by the Cancer Vaccine Consortium as its ELISPOT reference laboratory and has been awarded a contract by the U.S. National Institutes of Health (NIH) to validate the ELISPOT assay for pre-clinical and clinical trials.
Thanks to its in-house expertise and rigorous procedures, CTL can conduct all assays in a GLP-compliant manner— whether to validate the test methods, to satisfy FDA requirements, or simply evaluating specimens for scientific significance. CTL also provides high-throughput data acquisition, evaluation, and quality control, allowing us to process large assays within a relatively short amount of time. For new clients, CTL can schedule an initial telephone conference to discuss how CTL products and services can assist the clients in achieving their goals.
